These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3618081)

  • 41. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
    De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the metabolism of calcium and phosphorus in the various phases of acromegaly and following the implantation of the pituitary gland with 90Y.
    MOLINATTI GM; CAMANNI F; LOSANA O; OLIVETTI M
    Acta Endocrinol (Copenh); 1961 Feb; 36():161-79. PubMed ID: 13771825
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery.
    Yan JL; Chang CN; Chuang CC; Hsu PW; Lin JD; Wei KC; Lee ST; Tseng JK; Pai PC; Chen YL
    J Formos Med Assoc; 2013 Jul; 112(7):416-20. PubMed ID: 23927981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.
    Barkan AL; Halasz I; Dornfeld KJ; Jaffe CA; Friberg RD; Chandler WF; Sandler HM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3187-91. PubMed ID: 9329336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term treatment of acromegaly with the somatostatin analogue SR-lanreotide.
    Suliman M; Jenkins R; Ross R; Powell T; Battersby R; Cullen DR
    J Endocrinol Invest; 1999 Jun; 22(6):409-18. PubMed ID: 10435849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours.
    Jadresic A; Banks LM; Child DF; Diamant L; Doyle FH; Fraser TR; Joplin GF
    Q J Med; 1982; 51(202):189-204. PubMed ID: 7111679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical use of cabergoline as primary and adjunctive treatment for acromegaly.
    Moyes VJ; Metcalfe KA; Drake WM
    Eur J Endocrinol; 2008 Nov; 159(5):541-5. PubMed ID: 18708434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of acromegaly by external irradiation.
    Macleod AF; Clarke DG; Pambakian H; Lowy C; Sonksen PH; Collins CD
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):303-14. PubMed ID: 2512038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bromocriptine therapy in acromegaly. A long-term review of 35 cases.
    Sachdev Y; Gopal K; Garg VK
    Postgrad Med J; 1981 Apr; 57(666):210-6. PubMed ID: 7027229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gamma knife stereotactic radiosurgery for acromegaly.
    Vik-Mo EO; Oksnes M; Pedersen PH; Wentzel-Larsen T; Rødahl E; Thorsen F; Schreiner T; Aanderud S; Lund-Johansen M
    Eur J Endocrinol; 2007 Sep; 157(3):255-63. PubMed ID: 17766706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pituitary irradiation in acromegaly.
    Aloia JF; Roginsky MS; Archambeau JO
    Am J Med Sci; 1974 Feb; 267(2):81-7. PubMed ID: 4821329
    [No Abstract]   [Full Text] [Related]  

  • 52. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion.
    van der Klaauw AA; Pereira AM; van Thiel SW; Smit JW; Corssmit EP; Biermasz NR; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Eur J Endocrinol; 2006 Jun; 154(6):851-8. PubMed ID: 16728545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long term follow-up of patients with Cushing's disease treated by interstitial irradiation.
    Sandler LM; Richards NT; Carr DH; Mashiter K; Joplin GF
    J Clin Endocrinol Metab; 1987 Sep; 65(3):441-7. PubMed ID: 3114299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sellar reconstitution and serum levels of growth hormone in acromegaly before and after pituitary implant.
    McLachlan MS; Wright AD; Doyle FH; Fraser TR
    Clin Radiol; 1971 Oct; 22(4):502-6. PubMed ID: 5135820
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy.
    Kinoshita Y; Tominaga A; Usui S; Arita K; Sakoguchi T; Sugiyama K; Kurisu K
    Neurosurg Rev; 2016 Apr; 39(2):313-8; discussion 318-9. PubMed ID: 26785642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.